Introduction
Bupivacaine is a local anesthetic compound belonging to the amino amide group. Its anesthetic effect is commonly related to its inhibitory effect on voltage-gated sodium channels, which are blocked in the inactivated state. 1, 2 However, several studies have shown that this drug can also inhibit K + channels by a different blocking mechanism. Voltage dependent K + channels, such as K v 1.1, KCNQ2/Q3 and HERG, 3 K ATP channels and K 2P channels are blocked by bupivacaine in different types of cells. 4, 5 In the cases where the inhibitory mechanism of K + channels was investigated, bupivacaine produced a characteristic open channel block. 6 The blocking of K + channels could explain the observed effects of bupivacaine on blood vessels. In particular, bupivacaine produced contraction of rat muscle arterioles 7 and of isolated human umbilical artery (HUA) rings. 8, 9 Additionally, Rossner et al. 10 
demonstrated that bupivacaine depolarized and increased
Bupivacaine is a local anesthetic compound belonging to the amino amide group. Its anesthetic effect is commonly related to its inhibitory effect on voltage-gated sodium channels. However, several studies have shown that this drug can also inhibit voltage-operated K + channels by a different blocking mechanism. This could explain the observed contractile effects of bupivacaine on blood vessels. Up to now, there were no previous reports in the literature about bupivacaine effects on large conductance voltage-and Ca 2+ -activated K + channels (BK Ca ). Using the patch-clamp technique, it is shown that bupivacaine inhibits single-channel and whole-cell K + currents carried by BK Ca channels in smooth muscle cells isolated from human umbilical artery (HUA). At the single-channel level bupivacaine produced, in a concentrationand voltage-dependent manner (IC 50 324 μM at +80 mV), a reduction of single-channel current amplitude and induced a flickery mode of the open channel state. Bupivacaine (300 μM) can also block whole-cell K + currents (~45% blockage) in which, under our working conditions, BK Ca is the main component. This study presents a new inhibitory effect of bupivacaine on an ion channel involved in different cell functions. Hence, the inhibitory effect of bupivacaine on BK Ca channel activity could affect different physiological functions where these channels are involved. Since bupivacaine is commonly used during labor and delivery, its effects on umbilical arteries, where this channel is highly expressed, should be taken into account.
intracellular Ca 2+ of cultured smooth muscle cells obtained from HUA.
Up to now, there are no reports of bupivacaine effects on large conductance voltage-and Ca 2+ -activated K + channels (BK Ca ). This channel is highly expressed in vascular smooth muscle cells and is functionally relevant being involved in the control of contractile properties in most blood vessels. In this study we demonstrate that bupivacaine can inhibit BK Ca in vascular smooth muscle cells isolated from HUA. Our results show that bupivacaine blocks BK Ca channel by inducing a reduction of its conductance, and a flickery mode of the open channel state. These results show a new effect of bupivacaine on a kind of channel highly expressed in HUA smooth muscle cells. Since umbilical arteries are important for the regulation of feto-placental blood flow, the demonstration that bupivacaine affects K + channels in this human artery is physiologically relevant.
In presence of 1.2 μM Ca 2+ , where the BK Ca channel has a high level of activity, bupivacaine (300 μM) produced a decrease in the amplitude of single-channel current and a flickery mode of the open channel state ( Fig. S2) . To further study the dosedependence of the blocking effect of this local anesthetic we recorded the channel activity at +60 mV using a solution with low Ca 2+ concentration in contact with the intracellular face of the membrane patch, so the channel displayed an adequate (not too high) level of activity. Figure 1A shows typical recordings with a single channel opening obtained in control condition, in the presence of 30, 100, 300 and 1,000 μM of bupivacaine in the BS, and after drug washout. It is possible to observe that
Results
The BK Ca channel is one of the K + channels frequently observed in inside-out patches obtained from human umbilical artery smooth muscle cells, as we described in a previous study. 11 Figure  S1 shows typical results which characterize this channel: increase of open probability (NPo) by augmenting free-Ca 2+ concentration to 1.2 μM ( Fig. S1A) , high selectivity to K + (P K /P choline > 15.77 and P K /P Cs > 15.77) ( Fig. S1B) , voltage-and Ca 2+ -dependence of NPo (Fig. S1C) , a single channel conductance of 234 ± 63 pS (Fig. S1D) , and complete blockage by 500 nM paxilline (a selective blocker of BK Ca channels) ( Fig. S1E) . that the blocking effect of bupivacaine is voltage dependent, that depolarization increases the drug affinity, and that the binding site for bupivacaine is located at ~46% of the way along the membrane field.
Another parameter that could have been analyzed was the NPo value of BK Ca channel as a function of bupivacaine concentration. However, because of bupivacaine-induced flickery mode of block, it was not possible to measure it precisely. The NPo value obtained from the area of the all-point histograms would have underestimated this parameter, while the value obtained from the idealized recording from single channel events detection by the half-amplitude threshold criterion would have overestimated it.
In order to test if the flickery block mode and the reduction in single channel current amplitude was enough to induce inhibition of macroscopic current we performed a series of experiments where the current was recorded in whole-cell configuration. The effect of bupivacaine was tested on a family of currents evoked by 500 ms voltage steps between -70 and +60 mV from a holding potential of -50 mV. In our experimental conditions (see wholesolutions in Methods), about 85% of the total control current was carried by BK Ca channels, as judged by sensitivity to 500 nM paxilline ( Fig. 2C and D) . Increasing the paxilline concentration did not augment the blocking effect (data not shown). The macroscopic current was partially blocked by superfusion with 300 μM bupivacaine ( Fig. 2A) and this effect was completely reversible ( Fig. 2A-C ) after 3 min of washing. Figure 2B shows the mean current-voltage relationships (I-V) of the steady-state current in control conditions, after the stable effect of bupivacaine and after washout. Subsequent to the current recovery, the same cell was superfused with a solution containing 500 nM paxilline and, after stabilization, paxilline plus bupivacaine to compare the effects of both drugs. While paxilline blocked whole-cell current almost completely, bupivacaine inhibited 44% of control current, and the effect of the two drugs applied together was not different from the effect of paxilline alone ( Fig. 2C and D) .
Discussion
The results presented in this study show that the local anesthetic bupivacaine inhibits BK Ca channels in HUA smooth muscle cells. This was demonstrated both at the single-channel level, as well as on whole-cell K + currents. Up to now, there have been no reports in the literature about the effects of bupivacaine on BK Ca channels. This channel is highly expressed in vascular smooth muscle cells and is functionally relevant, being involved in the control of contractile properties in most blood vessels.
In the single-channel configuration the ionic selectivity analysis, the voltage and paxilline sensitivity, the conductance value, and the increase in open probability when the intracellular Ca 2+ concentration was elevated, all indicate that the channel blocked by bupivacaine is the BK Ca channel. This drug is able to block the BK Ca channel both during its activation by low micromolar free Ca 2+ and in the presence of a modest intracellular Ca 2+ concentration, where the open probability was lower. In this latter condition, the analysis of the blocking effect was investigated bupivacaine, in a concentration-dependent manner, produced a reduction of single-channel BK Ca current amplitude and induced a clear flickery mode of the open channel state observed as an increase in the noise of the open channel level. To quantify the reduction in current amplitude we obtained the mean amplitude of the control and of the flickery-blocked channel from the allpoint histogram distributions from 250 ms of a single channel recording as described in Methods (Fig. 1B) . The histograms were fitted with a Gaussian function with two components obtaining the mean current amplitudes of the open and closed state (μ o and μ c , respectively), together with the standard deviation (σ o ) of the open peak, which can be taken as a measure of bupivacaine-induced current flicker. Mean values for single channel current amplitude (μ = μ o -μ c ) and σ o as function of bupivacaine concentration are depicted in Figure 1C and D, where it can be seen that as bupivacaine concentration rose, the current amplitude (μ) significantly diminished, while the noise (σ o ) increased. These effects were completely reversible after washout ( Fig. 1C and D) . The effect of bupivacaine was quick, both in its onset and in the reversal of its block after washout. After 30 sec of perfusion bupivacaine effect was already stable, while it disappeared completely after 1 min of washout. The reduction effect in the single channel open current amplitude as a function of time is shown in Figure S3 .
To explore the voltage-dependence of bupivacaine BK Ca channel block, the mean amplitude of BK Ca single-channel currents were measured at each bupivacaine concentration and at different membrane potentials. The blocked current values (i B ) were normalized to the current without block (i c ) and this relationship (i B /i c ) plotted vs. the logarithm of bupivacaine concentration (Fig. 1E) ; the resulting data points were fitted with the following equation:
where x is the logarithm of bupivacaine concentration and h is the Hill slope. 12, 13 From this equation, one can obtain the drug dissociation constant (K D ) which represents the bupivacaine concentration that produces 50% current inhibition (IC 50 ) at each membrane potential. The K D calculated for different membrane potentials were statistically different and Figure 1F shows these values plotted as a function of the membrane potential. This relationship was well-fitted by an exponential decay function: 12, 13 where K D (0) is the K D value at 0 mV, z is the valence of the blocker (+1 in this case), V is the voltage across the membrane, δ is the location of the blocking site in terms of the fraction of the electrical field (the electrical distance) measured from the inside of the membrane, and RT/f = 25.3 mV at 22°C. A K D (0) of 1,444 μM and a δ of 0.46 were obtained from the best fit to the graph shown in Figure 1F . Together, these results suggest depolarizing step, as the current in presence of bupivacaine had lower amplitude than in control conditions but maintained the kinetics of activation for each voltage pulse. Since the combination of bupivacaine plus paxilline did not produce an additive block, we can conclude that 300 μM bupivacaine partially blocks the BK Ca macroscopic current in accordance with the singlechannel results. The effect of bupivacaine on this channel shows that this drug presents different blocking mechanisms depending on the type of ionic channel involved; e.g., Nilsson et al. reported an open channel block mode for two types of K V channels.
Regarding the drug accessibility to the channel, the analysis of unitary currents suggests that the site of action is located on the internal side of the channel. Moreover, as bupivacaine is a molecule that can readily cross the plasma membrane, one could expect it to be effective on BK Ca channels when applied on either side of the membrane. This idea is consistent with our data obtained from whole-cell and inside-out patch recording configurations, as we observed that bupivacaine is able to readily block the channel when applied to either the external or internal side of the plasma membrane.
BK Ca channels are widely expressed and involved in different and relevant physiological functions in different types of in more detail. In IO patches, bupivacaine quickly induced a flickering open channel behavior observed as an increase in the noise of the open channel level (estimated by σ o ) and a clear and significant concentration-dependent reduction of single-channel current amplitude. All these effects were reversible following washout of bupivacaine from the bath. We also observed that bupivacaine blocking effect was voltage-dependent, since the drug K D changed e-fold per 54.7 mV (decreasing with depolarization), indicating that the drug binding is affected by the membrane electrical field, probably by facilitating its entrance into the pore region of the channel. The calculated value of the electrical distance of block suggests that the binding site for this drug is located at ~46% of the way along the membrane field, measured from the inside of the membrane. These results can be compared with those reported for intracellular effects of other BK Ca channel blockers, such as TEA and Cs + . 14 Bupivacaine can also block whole-cell K + currents in which, under our working conditions, BK Ca is a main component. Timedependent block by bupivacaine has been reported for some subtypes of K V channels, suggesting that bupivacaine has a selective affinity for the open channel state. 6 In our case, 300 μM of bupivacaine did not induce any time-dependent block during the (C) superimposed representative recordings of currents evoked by single steps to +40 mV from a holding potential of -50 mV obtained in a cell which was exposed sequentially to control conditions, then to 300 μM bupivacaine, to washout of bupivacaine followed by 500 nM paxilline and finally, 300 μM bupivacaine plus 500 nM paxilline. (D) Mean ± SEM values for the protocol shown in (C) (n = 3-10). The symbol * and the symbol # indicate statistically significant difference vs. control conditions and vs. 300 μM bupivacaine, respectively, by ANOVA followed by Holm-Sidak test (p < 0.05).
the treated tissue using a Pasteur pipette. The remaining tissue and the supernatant containing isolated cells were stored at room temperature (~22°C) until used. HUA smooth muscle cells were allowed to settle onto the coverglass bottom of a 3 ml experimental chamber.
Patch-clamp current recordings. The isolated HUA smooth muscle cells were observed with a mechanically stabilized, inverted microscope (Telaval 3, Carl Zeiss, Jena) equipped with a 40x objective lens. Application of test solutions was performed through a multibarreled pipette positioned close to the cell investigated. After each experiment on a single cell, the experimental chamber was replaced by another one containing a new sample of cells. Only well-relaxed, spindle-shaped smooth muscle cells were used for electrophysiological recordings. Data were collected within 4-6 h after cell isolation. All experiments were performed at room temperature (~22°C).
The standard tight-seal inside-out and whole-cell configurations of the patch-clamp technique 24 were used to record single-channel and macroscopic currents respectively. Glass pipettes were drawn from WPI PG52165-4 glass on a two-stage vertical micropipette puller (PP-83, Narishige Scientific Instrument Laboratories) and pipette resistance ranged from 2 to 4 MΩ.
Single-channel recordings. Single-channel currents were recorded in the inside-out configuration (IO), filtered with a 4-pole lowpass Bessel filter at 2 kHz (Axopatch 200A amplifier, Molecular Devices) and digitized (Digidata 1200 Axon Instruments) at 16 kHz. Voltage-clamp 30-60 sec recordings were obtained at different membrane potentials to obtain the single channel current amplitude and the open probability (NPo) of the channels. The control pipette solution (PS) used for single-channel recordings contained (in mM): 140 KCl, 0.5 MgCl 2 , 10 HEPES, 6 glucose, 1 CaCl 2 , 5 4-aminopirydine (4-AP), pH adjusted to 7.4 with HCl. 4-AP was added to block K v channels present is HUA smooth muscle cells. 11 The bath solution (BS) in contact with the cytosolic face of the membrane contained (in mM): 140 KCl, 0.5 MgCl 2 , 10 HEPES, 6 Glucose, 1 EGTA, pH adjusted to 7.4 with KOH. Different amounts of CaCl 2 were added to the BS to obtain the desired free Ca 2+ concentrations tested (1.2 μM or 3 nM; calculated using Maxchelator software from Stanford University: maxchelator.stanford.edu).
In order to obtain the relative permeability of the channel to different cations, the BS was modified for some of the experiments: KCl was totally replaced with either 140 mM of CsCl or with 140 mM choline chloride. In these cases, the free Ca 2+ concentration was 1.2 μM, which provides adequate activity of BK Ca channel over a wide range of membrane potentials. Different concentrations of bupivacaine (30, 100, 300 and 1,000 μM) were added to the BS to study voltage-and concentrationdependent effects of this drug on BK Ca channels.
Single-channel currents were analyzed with the pCLAMP software (version 9.2). Current amplitude histograms were plotted for each membrane potential tested to obtain a current-voltage relationship for the study of single channel properties. Open probability is expressed as NPo, where N is the number of single cells. Activation of these channels induced by an increase in the intracellular Ca 2+ concentration produces hyperpolarization of the cell membrane, thereby diminishing membrane excitability. This is important for the regulation of different cell mechanisms, like contractility of smooth muscle cells 15 or action potential frequency, duration, and inter-burst intervals in neurons. 16 So, the inhibitory effect of bupivacaine on BK Ca channel activity could affect different physiological functions. In particular, our results give an explanation for the previously described bupivacaine effect on HUA rings, where Rossner et al. observed that this drug produced depolarization and contraction of this vessel.
In obstetrics bupivacaine is commonly used during labor and delivery. Placental transfer of this drug has been confirmed by the presence of measurable quantities of bupivacaine in umbilical cord blood. 17 Although there are several studies that indicate that bupivacaine use is safe for the mother and fetus, [18] [19] [20] it has been shown in rats that a considerable amount of bupivacaine is taken up by both sides of the placenta, as well as the amnion and myometrium. 21 Moreover, Monuszko et al. suggest that unintentional intravascular injection of bupivacaine intended to be epidural may lead to plasma concentrations sufficiently high to cause umbilical vessel contraction with adverse fetal effects. Since BK Ca channels are important for the regulation of human umbilical artery tone, we think that the fact that bupivacaine blocks these channels in this human vessel should be taken into account when using this anesthetic.
In summary, this study presents a new inhibitory effect of bupivacaine on a K + channel involved in several cell functions and particularly, highly expressed in vascular smooth muscle cells.
Methods
Umbilical cords were obtained from normal, term pregnancies after vaginal and cesarean deliveries, placed in transport solution of the following composition (in mM): 130 NaCl, 4.7 KCl, 1.17 KH 2 PO 4 , 1.16 MgSO 4 , 24 NaCO 3 H, 2.5 CaCl 2 , pH 7.4 at 4°C and immediately taken to our laboratory where they were stored at 4°C and used within the next 24 hs. All procedures are in accordance with the declaration of Helsinki (1975) .
Cell isolation procedure for patch-clamp experiments. The HUA were dissected from the Wharton's jelly just before the cell isolation procedure. HUA smooth muscle cells were obtained by a method based on the one described by Klockner et al. and later modified in our laboratory in order to diminish the enzyme content in the dissociation medium (DM). 23 Briefly, a segment of HUA was cleaned of any residual connective tissue, cut in small strips, and placed for 15 min in a DM containing (in mM): 140 NaCl, 5 KH 2 PO 4 , 5 MgCl 2 , 6 glucose, 5 HEPES; pH was adjusted to 7.4 with NaOH. The strips were then placed in DM with 2 mg/ml collagenase type I during 25 min, with gentle agitation, at 35°C. After the incubation period the strips were washed with DM and single HUA smooth muscle cells were obtained by a gentle dispersion of curves. Fitting parameters, mean (μ) and standard deviation (σ), were used to analyze current amplitude (μ open -μ closed ) and open channel noise (σ open ) in absence and presence of 30, 100, 300 and 1,000 μM bupivacaine and after washout. Analysis of dose-response relationships at different membrane potentials was performed using the sigmoidal dose-response (variable slope) curve fitting on GraphPad Prism 4.0. Voltage dependence of K D was fitted with a single exponential decay (Origin Pro 8 Software), in order to obtain δ (see Results for more details).
Whole-cell recordings. Whole-cell currents were filtered with a 4-pole lowpass Bessel filter (Axopatch 200A amplifier) at 2 kHz and digitized (Digidata 1200 Molecular Devices) at a sample frequency of 20 kHz. The experimental recordings were stored on a computer hard disk for later analysis. The pipette solution contained (in mM): 130 KCl, 10 HEPES, 0.1 EGTA, 1 MgCl 2 , 0.1 CaCl 2 , 5 ATP-Na 2 ; pH was adjusted to 7.4 with KOH giving a calculated free Ca 2+ concentration of 0.7 μM. The bath solution contained (in mM): 130 NaCl, 5.4 KCl, 1.2 MgCl 2 , 2.5 CaCl 2 , 5 HEPES, 6 glucose, 5 4-AP; pH was adjusted to 7.4 with HCl. Under these conditions K ATP and Kv channels contribution to the macroscopic current are inhibited by ATP-Na 2 and 4-AP, respectively, 11 while the intracellular free Ca 2+ concentration ensures a significant BK Ca -carried current component. Whole-cell current stability was monitored by applying successive 500 ms voltage steps (from a holding potential of -50 mV to a test potential of +40 mV) discarding those cells in which the current amplitude did not remain constant in time. After the current was stable, this same voltage-clamp step protocol was applied in control or in the different experimental conditions (300 μM bupivacaine, 500 nM paxilline, or bupivacaine and paxilline together). A family of voltage steps between -70 and +60 mV from a holding potential of -50 mV were also applied in each stable condition for further current-voltage relationship (I-V) analysis. Cell membrane capacitance was calculated from the capacity current obtained from the recording of a single 10 mV hyperpolarizing step.
Drugs and reagents used. Bupivacaine hydrochloride, paxilline, 4-aminopyridine (4-AP), EGTA, Na 2 ATP, and all the enzymes used for cell isolation were purchased from Sigma Chemical Co. All other reagents were of analytical grade and purchased from local vendors. Bupivacaine was dissolved in distilled water. Paxilline was dissolved in DMSO. Fresh aliquots of stock solutions of paxilline and bupivacaine were added to the bath solution on the day of the experiment. When comparing with paxilline effects, an appropriate amount of DMSO was added to all solutions without paxilline.
Statistics. The results are expressed as mean ± standard error of the mean. Paired or unpaired Student's t-tests were used to compare two groups. For the comparison of multiple groups, ANOVA followed by an appropriate test was used. In all cases, a p value lower than 0.05 was considered for establishing statistically significant differences.
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No potential conflicts of interest were disclosed. channels present in each patch. NPo values were calculated using the following expression:
where T is the duration of recording and t j is the time spent with j = 1,2,3,…n channels open. The parameters were obtained from single channel events detection by the half-amplitude threshold criterion. Stationary conditions of single channel recordings were controlled by plotting the NPo values calculated for intervals of 5 sec during the 30 sec of recording as function of time. The NPo values in control conditions were stable during the recording time in all studied patches.
The K + selectivity of the channel was tested by studying the relative permeabilities of Cs + and choline to K + under conditions of zero net current. These were estimated by analyzing the shift in the reversal potential under biionic conditions. 25 The relationship between the permeability ratio and the shift in reversal potential was obtained from the Goldman-Hodgkin-Katz equation. 26, 27 If K + in contact with the inner surface of the membrane is replaced equimolarly by X + while not altering the K + concentration in contact with the outward membrane surface, the shift in reversal potential is given by:
where V x and V K are the reversal potentials with X + and K + at the inner membrane surface, respectively; P x and P k are the permeabilities of the channel to X + and K + , respectively; K o , K i ; and X i are the concentrations of the indicated ions; and F/RT = 0.0394 mV -1 at 22°C. The permeability ratio of X + to K + is then obtained by rearrangement:
For the selectivity experiments presented in this paper, K o and K i were both 140 mM, so that V K = 0. Data for determining reversal potentials were obtained by plots of single channel current amplitude vs. membrane potential, which were nonlinear for the ions studied. 28 In the experiments where reversal of the currents was not observed at the range of membrane potential tested, "reversal potentials" are reported as greater than the highest membrane potential tested.
Because bupivacaine decreased single channel current amplitude and increased the open channel noise (see results), the voltage-and dose-dependent blocking effect of bupivacaine on BK Ca channel was analyzed on all-points amplitude histograms obtained from portions of single channel recordings of 250 ms of length chosen so the open channel time was the same as the closed channel time. A nonlinear Levenberg-Marquardt least squares curve fitting procedure was used for fitting Gaussian
